Docetaxel Injection
Product Images NDC 25021-254

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Docetaxel (NDC 25021-254). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Doc0b 0000 01)

FDA Label Image

Figure 1 (Doc0b 0000 02)

FDA Label Image

Figure 2 (Doc0b 0000 03)

FDA Label Image

Figure 3 (Doc0b 0000 04)

FDA Label Image

Figure 4 (Doc0b 0000 05)

The text provided is not readable.*

FDA Label Image

Figure 5 (Doc0b 0000 06)

FDA Label Image

Figure 6 (Doc0b 0000 07)

FDA Label Image

Figure 7 (Doc0b 0000 08)

FDA Label Image

Figure 8 (Doc0b 0000 09)

This text provides information about the PFS Probability (%) and Progression Free Survival Time (months). The PFS probability values are listed as 12%, 18%, 20%, and 30%. The Progression Free Survival Time is mentioned as 36 months.*

FDA Label Image

Figure 9 (Doc0b 0000 10)

FDA Label Image

Figure 10 (Doc0b 0000 11)

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Doc0b 0000 12)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.